Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR17 | Q13304 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2724384 | 0.80 | GPR17 (0.49) | GPR17KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL9452228 | 0.75 | HPGD (0.57) | GPR17KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL2724876 | 0.74 | KDM4E (0.61) | KDM4EALDH1A1HPGDMEN1POLB | |
| SCHEMBL31245675 | 0.74 | KDM4E (0.61) | KDM4EALDH1A1HPGDMEN1POLB | |
| SCHEMBL5027261 | 0.73 | KDM4E (0.47) | GPR17KDM4EALDH1A1PARP1 | |
| SCHEMBL48966 | 0.69 | IMPDH2 (0.47) | GPR17KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL27760409 | 0.69 | PARP1 (0.54) | GPR17KDM4EALDH1A1HPGDPARP1 | |
| SCHEMBL29350550 | 0.69 | IMPDH2 (0.47) | GPR17KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL8752557 | 0.69 | GPR17 (0.58) | GPR17HPGDMEN1KMT2A | |
| SCHEMBL15516976 | 0.68 | MCL1 (0.44) | GPR17KDM4EALDH1A1HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012059568-A1 | NOVEL WATER-SOLUBLE INDOLOBENZAZEPINE MOLECULES DEMONSTRATING ANTIMITOTIC, ANTIVASCULAR, AND ANTITUMOR ACTIVITIES IN VIVO | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2012-05-10 | — | — | WO | disclosed |